Aurobindo Pharma Ltd. (ARBN)

NSE


Symbol		Exchange		Currency
ARBN	·	NSE	·	INR	Real-time
ARBNc1:NS	·	NSE	·	INR	Delayed
ARBNc2:NS	·	NSE	·	INR	Delayed
ARBNc3:NS	·	NSE	·	INR	Delayed
ARBN	·	BSE	·	INR	Delayed

Currency in INR

ARBN Pro Research

1,658.60

+0.60(+0.04%)

Real-time Data·00:45:13

Fair Value

Unlock Value

Day's Range

1,653.00

1,666.10

52 wk Range

1,016.10

1,671.90

ARBN Income Statement

Assess the Aurobindo Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ARBN net worth.

Period Ending:

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

2026

31/03

Total Revenues

aa.aa

234,554.9

248,553.8

290,018.7

317,237.3

336,530.8

Total Revenues Growth

aa.aa

-5.32%

+5.97%

+16.68%

+9.39%

+6.08%

Cost Of Revenues

aa.aa

104,498.8

116,416.7

129,856.9

134,838.6

139,875.1

Gross Profit

aa.aa

130,056.1

132,137.1

160,161.8

182,398.7

196,655.7

Gross Profit Growth

aa.aa

-10.83%

+1.6%

+21.21%

+13.88%

+7.82%

Gross Profit Margin %

aa.aa

55.45%

53.16%

55.22%

57.5%

58.44%

Other Operating Expenses, Total

aa.aa

96,991.8

107,018.2

116,246.7

131,985

145,142.1

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-4.27%	+10.34%	+8.62%	+13.54%	+9.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	35,751.1	36,560.1	40,433.6	45,469.6	52,467.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	49,975.5	58,082.6	60,894	70,603.4	75,067.9

Operating Income

aa.aa

33,064.3

25,118.9

43,915.1

50,413.7

51,513.6

Operating Income Growth

aa.aa

-25.76%

-24.03%

+74.83%

+14.8%

+2.18%

EBIT Margin %

aa.aa

14.1%

10.11%

15.14%

15.89%

15.31%

Net Interest Expenses

aa.aa

-18.7

195.7

202.1

-839.8

-209.6

Net Interest Expenses Growth

aa.aa

+94.97%

+1,146.52%

+3.27%

-515.54%

+75.04%

Interest Expense, Total

aa.aa

-368.4

-1,289.5

-2,680.9

-4,403.9

-3,523.1

Interest And Investment Income

aa.aa

349.7

1,485.2

2,883

3,564.1

3,313.5

Other Non Operating Expenses, Total

aa.aa

1,415.3

857.9

1,888.6

1,418.2

1,150.7

EBT, Excl. Unusual Items

aa.aa

34,460.9

26,172.5

46,005.8

50,992.1

52,454.7

Gain (Loss) On Sale Of Assets

aa.aa

-400.2

132.3

234.9

-89.4

-243

Other Unusual Items, Total

aa.aa

-624.1

-109.5

-1,427.8

-478.9

-1,107.4

EBT, Incl. Unusual Items

aa.aa

33,727.4

26,125

43,799.9

50,662.9

51,118.5

EBT, Incl. Unusual Items Growth

aa.aa

-54.07%

-22.54%

+67.66%

+15.67%

+0.9%

EBT, Incl. Unusual Items Margin

aa.aa

14.38%

10.51%

15.1%

15.97%

15.19%

Income Tax Expense

aa.aa

7,256.3

6,848.5

12,110.2

15,827.2

16,088.8

Net Income to Company

aa.aa

26,471.1

19,276.5

31,689.7

34,835.7

35,029.7

Minority Interest

aa.aa

10.4

-1.5

23.1

17.8

Net Income

aa.aa

26,481.5

19,275

31,729.7

34,858.8

35,047.5

Net Income Growth

aa.aa

-50.36%

-27.21%

+64.62%

+9.86%

+0.54%

Net Income Margin %

aa.aa

11.29%

7.75%

10.94%

10.99%

10.41%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

26,481.5

19,275

31,729.7

34,858.8

35,047.5

Basic EPS - Continuing Operations

aa.aa

45.2

32.9

54.15

59.81

60.34

Basic EPS - Continuing Operations Growth

aa.aa

-50.36%

-27.21%

+64.62%

+10.44%

+0.9%

Diluted EPS - Continuing Operations

aa.aa

45.19

32.9

54.15

59.81

60.34

Diluted EPS - Continuing Operations Growth

aa.aa

-50.37%

-27.21%

+64.62%

+10.44%

+0.89%

Basic Weighted Average Shares Outstanding

aa.aa

585.94

582.87

580.8

Diluted Weighted Average Shares Outstanding

aa.aa

585.94

582.87

580.8

Dividend Per Share

aa.aa

4.5

Dividend Per Share Growth

aa.aa

+125%

-66.67%

+50%

EBITDA

aa.aa

43,114.2

36,344.1

57,641.2

64,905.9

67,795.5

EBITDA Growth

aa.aa

-20.08%

-15.7%

+58.6%

+12.6%

+4.45%

EBITDA Margin %

aa.aa

18.38%

14.62%

19.87%

20.46%

20.15%

EBIT

aa.aa

33,064.3

25,118.9

43,915.1

50,413.7

51,513.6

* In Millions of INR (except for per share items)

FAQ

What was Aurobindo Pharma’s revenue at year end?

At the end of the last reported fiscal year, Aurobindo Pharma (ARBN) recorded total revenue of 336,530.80 million INR.

How much revenue did Aurobindo Pharma report in the most recent quarter?

In its most recent quarterly earnings report, Aurobindo Pharma posted revenue of 91,503.50 million INR.

What was Aurobindo Pharma’s net income for the year?

For the full year, Aurobindo Pharma reported net income of 35,047.50 million INR.

How much net income did Aurobindo Pharma post in the last quarter?

In the most recent quarter, Aurobindo Pharma (ARBN) posted net income of 10,325.60 million INR.

What was Aurobindo Pharma’s gross profit for the year?

Gross profit for the year was reported at 196,655.70 million INR.

How much gross profit did Aurobindo Pharma generate last quarter?

Aurobindo Pharma recorded gross profit of 55,234.00 million INR in its latest quarterly report.

What was Aurobindo Pharma’s annual operating income?

For the full year, Aurobindo Pharma (ARBN) reported operating income of 51,513.60 million INR.

What was Aurobindo Pharma’s operating income last quarter?

Quarterly operating income was 13,942.40 million INR.

What was Aurobindo Pharma’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 18,012.88 million INR.

What was the quarter-over-quarter change in EBITDA for Aurobindo Pharma?

EBITDA changed by -0.10% million INR compared to the last quarter.

What is Aurobindo Pharma’s most recent gross profit margin?

The latest reported gross profit margin for Aurobindo Pharma (ARBN) is 60.36% million INR.

What is Aurobindo Pharma’s most recent net income margin?

Net income margin based on recent financials is 11.28% million INR.

What is Aurobindo Pharma’s most recent EBIT margin?

Aurobindo Pharma reported an EBIT margin of 15.24% million INR based on current figures.

How did Aurobindo Pharma’s revenue change compared to the previous quarter?

Revenue changed by 3.35% million INR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Aurobindo Pharma?

In the latest quarter, gross profit changed by 12.15% million INR from the previous quarter.

S&P/TSX

36,475.92

+17.59

+0.05%

S&P/TSX 60

2,143.34

-0.49

-0.02%

US 30

53,783.50

-8.5

-0.02%

US 500

7,734.10

+6.0

+0.08%

S&P 500 VIX

15.28

-0.18

-1.16%

DAX

26,391.42

+67.54

+0.26%

Dollar Index

99.762

+0.047

+0.05%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.85	+0.20%	30.51M
RBC	293.12	-0.33%	2.55M
Shopify Inc	212.30	-1.76%	3.42M
Bank of Montreal	252.33	-0.45%	2.74M
Suncor Energy	88.25	+0.88%	7.61M
Canadian Imperial Bank	165.64	-0.41%	3.19M
Manulife Financial	61.04	-0.81%	8.04M

Name	Last	Chg. %	Vol.
Aitenders Tech	0.80	+900.00%	1.50K
Pharmadrug	0.01	+200.00%	255.50K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ImagineAR	0.010	+100.00%	152.01K
ePlay Digital	0.010	+100.00%	7.00K
Pharmadrug	0.0100	+100.00%	255.50K
Digicann Ventures	0.010	+100.00%	2.00K

Name	Last	Chg. %	Vol.
1933 Industries	0.01	-100.00%	52.40K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Playground Ventures	0.010	-50.00%	3.00K
James Bay Resources Ltd	0.010	-50.00%	1.00K
Albert Labs International	0.005	-50.00%	1.00K
Mcf Energy	0.02	-50.00%	481.08K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	27.27	+5.90%	4.68M
Keel Infra	4.61	-2.54%	2.81M
Aurora Cannabis	5.030	+24.81%	2.13M
Celestica Inc.	432.72	-1.66%	366.97K
Constellation Software	3,220.61	-2.53%	67.27K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaaaaa	33.36	+59.41%	53.18
Aaaa Aaa Aaaaa	2.910	+59.01%	4.627
Aa Aaaa	5.18	+48.35%	7.68
A Aaaaaa Aaaaaaaaaa	104.29	+47.42%	153.74
Aa Aaa A Aaaaaa	143.04	+47.21%	210.57
Aaa Aaaaaaaaaa Aa	17.42	+40.55%	24.48
Aaaaa	7.05	+38.16%	9.74

Name	Last	Upside	Fair Value
Aa Aaaaaaaa	33.36	+59.41%	53.18
Aaaa Aaa Aaaaa	2.910	+59.01%	4.627
Aa Aaaa	5.18	+48.35%	7.68
A Aaaaaa Aaaaaaaaaa	104.29	+47.42%	153.74
Aa Aaa A Aaaaaa	143.04	+47.21%	210.57
Aaa Aaaaaaaaaa Aa	17.42	+40.55%	24.48
Aaaaa	7.05	+38.16%	9.74

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Aurobindo Pharma Ltd. (ARBN)

ARBN Income Statement

FAQ

What was Aurobindo Pharma’s revenue at year end?

How much revenue did Aurobindo Pharma report in the most recent quarter?

What was Aurobindo Pharma’s net income for the year?

How much net income did Aurobindo Pharma post in the last quarter?

What was Aurobindo Pharma’s gross profit for the year?

How much gross profit did Aurobindo Pharma generate last quarter?

What was Aurobindo Pharma’s annual operating income?

What was Aurobindo Pharma’s operating income last quarter?

What was Aurobindo Pharma’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Aurobindo Pharma?

What is Aurobindo Pharma’s most recent gross profit margin?

What is Aurobindo Pharma’s most recent net income margin?

What is Aurobindo Pharma’s most recent EBIT margin?

How did Aurobindo Pharma’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Aurobindo Pharma?

Trending Stocks